Anlon Healthcare Limited has informed the Exchange regarding 'Anlon Healthcare Limited has informed the Exchange that the Board of Directors at its meeting held on March 06, 2026, has considered and approved 1. Sub-division of equity shares from face value of Rs.10/- each to face value of Rs.02/- each., 2. Alteration of Capital Clause of the Memorandum of Association of the Company Subsequent to Sub-Division of Equity Shares, 3. Increase in Authorised Share Capital and Consequent Alteration to the Capital Clause of the Memorandum of Association, 4. Issue of Bonus Shares in the ratio of 1:1.'.

Anlon Healthcare's board, at its meeting on March 6, 2026, approved three major corporate actions. First, a sub-division of equity shares from face value of Rs.10 to Rs.2, splitting each share into 5 (a 1:5 stock split). Second, an increase in authorized share capital from Rs.55 crore to Rs.110 crore to accommodate further issuances. Third, a bonus issue in the ratio of 1:1, meaning 1 bonus share for every 1 share held, totaling about 2.65 crore new shares worth Rs.53.15 crore, to be issued out of free reserves (Rs.147.08 crore available as of Dec 31, 2025). A postal ballot and e-voting process will be initiated to seek shareholder approval, with the record date to be determined later. Bonus shares are expected to be credited within 2 months, on or before May 6, 2026.